Identification and validation of heterotypic cell-in-cell structure as an adverse prognostic predictor for young patients of resectable pancreatic ductal adenocarcinoma
Open Access
- 20 October 2020
- journal article
- letter
- Published by Springer Science and Business Media LLC in Signal Transduction and Targeted Therapy
- Vol. 5 (1), 1-3
- https://doi.org/10.1038/s41392-020-00346-w
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31671432, 81572799)
- National Key Research & Development Program of China
- National Natural Science Foundation of China
- National Key Research & Development Program of China
- National Natural Science Foundation of China
This publication has 5 references indexed in Scilit:
- Mechanical Ring Interfaces between Adherens Junction and Contractile Actomyosin to Coordinate Entotic Cell-in-Cell FormationCell Reports, 2020
- 21-Gene Recurrence Score Assay and Outcomes of Adjuvant Radiotherapy in Elderly Women With Early-Stage Breast Cancer After Breast-Conserving SurgeryFrontiers in Oncology, 2019
- Strategies for Increasing Pancreatic Tumor ImmunogenicityClinical Cancer Research, 2017
- Mammalian Cell Competitions, Cell-in-Cell Phenomena and Their Biomedical Implications.Current Molecular Medicine, 2015
- Detecting cell-in-cell structures in human tumor samples by E-cadherin/CD68/CD45 triple stainingOncotarget, 2015